METHODOLOGICAL APPROACHES TO DEVELOPING AND CERTIFYING A STANDARD HUMAN IMMUNOGLOBULIN SAMPLE TO DETERMINE ANTICOMPLEMENTARY ACTIVITY
- Authors: Krivikh M.A.1, Kornilova O.G.1, Khusnatdinova E.A.1, Bunyatyan N.D.2,1, Olefir Y.V.1
-
Affiliations:
- Research Center for Examination of Medical Products, Ministry of Health of the Russian Federation
- First Moscow state medical UNIVERSITY. I. M. Sechenova (Sechenov University) Of The Ministry Of Health Of Russia
- Issue: Vol 69, No 3 (2020)
- Pages: 36-43
- Section: Articles
- URL: https://journals.eco-vector.com/0367-3014/article/view/113303
- DOI: https://doi.org/10.29296/25419218-2020-03-05
- ID: 113303
Cite item
Abstract
Full Text
About the authors
Maksim Andreevich Krivikh
Research Center for Examination of Medical Products, Ministry of Health of the Russian Federation
Email: Krivykh@expmed.ru
Chief Expert of the Division for Expert Evaluation of Allergenes, Cytokines and Other Immunomodulators of the Center for Evaluation and Control of Medicinal Immunobiological Products, PhD 8, Petrovsky Boulevard, Build. 2, Moscow 127051, Russian Federation
Ol'ga Gennagievna Kornilova
Research Center for Examination of Medical Products, Ministry of Health of the Russian Federation
Email: Kornilova@expmed.ru
Chief expert of the laboratory of immunoglobulin and blood products of Testing Centre for quality expertise of medical immunobiological preparatios 8, Petrovsky Boulevard, Build. 2, Moscow 127051, Russian Federation
Ekaterina Aleksandrovna Khusnatdinova
Research Center for Examination of Medical Products, Ministry of Health of the Russian Federation
Email: Husnatdinova@expmed.ru
Expert of the Laboratory of Immunoglobulins and Blood Products Chief expert of the laboratory of immunoglobulin and blood products of Testing Centre for quality expertise of medical immunobiological preparatios 8, Petrovsky Boulevard, Build. 2, Moscow 127051, Russian Federation
Nataliya Dmitrievna Bunyatyan
First Moscow state medical UNIVERSITY. I. M. Sechenova (Sechenov University) Of The Ministry Of Health Of Russia; Research Center for Examination of Medical Products, Ministry of Health of the Russian Federation
Email: ndbun@mail.ru
Head of the Department of pharmaceutical technology and pharmacology; сhief Research associate of the Clinical Pharmacology Centre, Doctor of Pharmaceutical Sciences, Professor 8, Petrovsky Boulevard, Build. 2, Moscow 127051, Russian Federation
Yuriiy Vital'evich Olefir
Research Center for Examination of Medical Products, Ministry of Health of the Russian Federation
Email: Olefir@expmed.ru
General Director, Doctor of Medical Sciences 8, Petrovsky Boulevard, Build. 2, Moscow 127051, Russian Federation
References
- Государственная фармакопея РФ XIV изд., ФС.3.3.2.0008.15 «Иммуноглобулин человека нормальный для внутривенного введения». [Электронное издание]. Режим доступа: http://femb.ru/feml
- Buchacher A., Schluga P., Mullner J. et al. Anticomplementary activity of IVIG concentrates - important assay parameters and impact of IgG polymers. Vox Sang. 2010; 98: 209-18. doi: 10.1111/j.1423-0410.2009.01271.x
- Государственный реестр лекарственных средств [Электронный ресурс] Режим доступа: http://grls.rosminzdrav. ru/Default.aspx (дата обращения: 25.07.2019)
- Определение антикомплементарной активности препаратов иммуноглобулинов. Методические рекомендации МЗ РСФСР. Горький. 1988; 1-12.
- Sandberg E. Collaborative study for establishment of human immunoglobulin biological reference preparation (BRP). Pharmeuropa Special Issue Bio. 1996; 1: 49-69.
- Кривых М.А., Корнилова О.Г., Бунятян Н.Д. и др. Аттестация стандартного образца иммуноглобулина человека для определения антикомплементарной активности. Химико-фармацевтический журнал. 2016; 50 (12): 61-4.
- Бондарев В.П., Борисевич И.В., Волкова Р.А. и др. Проблемы аттестации отраслевых стандартных образцов для контроля качества иммунобиологических лекарственных препаратов. Ведомости НЦЭСМП. 2013; 2: 28-32. doi: 10.30895/1991-2919-2013-0-2
- Государственная фармакопея РФ XIV изд., ОФС.1.8.2.0007.15 «Определение антикомплементарной активности лекарственных препаратов иммуноглобулинов человека для внутривенного введения». [Электронное издание]. Режим доступа: http://femb.ru/feml
- European Pharmacopoeia 9.1, 01/2010:20617 corrected 7.6 «Test for anticomplementary activity of immunoglobulin». [Электронное издание]. Режим доступа: http://online6.edqm. eu/ep901/# (дата обращения: 25.07.2019).
- Гланц С. Медико-биологическая статистика. Пер. с англ. М.: Практика, 1999; 459.
- Sandberg E., Daas A., Esposito-Farese M.E. Collaborative study for establishment of human immunoglobulin European pharmacopoeia biological reference preparation batch 2. Pharmeuropa Special Issue Bio. 2001; 1: 27-42.
- Sandberg E., Behr-Gross M.-E., Daas A. Collaborative study to establish human immunoglobulin BRP batch 3 and human immunoglobulin (molecular size) BRP Batch 1. Pharmeuropa Bio. 2006; 1: 37-48.
- Sandberg E., Costanzo A., Daas A. et al. Calibration of the human immunoglobulin BRPs for ACA and molecular size (batch 1) and for Fc function and molecular size (batchs 1&2). Pharmeuropa Bio&SN. 2012; 1-15.
- Karra D., Regourd E., Costanzo A. Collaborative study for the establishment of the human immunoglobulin BRP replacement batches. Pharmeuropa Bio&Sci Notes. 2018; 3: 37-61.
- Корнилова О.Г., Кривых М.А., Хуснатдинова E.A. и др. Изучение возможности увеличения срока годности стандартного образца иммуноглобулина человека для определения антикомплементарной активности. БИОпрепараты. Профилактика, диагностика, лечение, 2017; 17 (2): 110-5.
- Корнилова О.Г., Хуснатдинова E.A., Коновалова E.C и др. Оценка стабильности аналитической работы методики определения антикомплементарной активности препаратов иммуноглобулинов человека. БИОпрепараты. Профилактика, диагностика, лечение, 2019; 19 (2): 118-23. doi: 10.30895/2221-996X-2019-19-2-118-123